Baseline biochemical and clinical predictors of castration resistance and survival in metastatic hormone-sensitive prostate cancer treated with first-line androgen receptor pathway inhibitors: A multicenter real-world study.
F. Verdasca(Administração Regional de Saúde de Lisboa e Vale do Tejo), João Gramaça(Administração Regional de Saúde de Lisboa e Vale do Tejo), I. Guerreiro(Administração Regional de Saúde de Lisboa e Vale do Tejo), I. Furtado(Administração Regional de Saúde de Lisboa e Vale do Tejo), Lúcia Gil(Administração Regional de Saúde de Lisboa e Vale do Tejo), R. Escaleira(Administração Regional de Saúde de Lisboa e Vale do Tejo), Madalena Machete(Escola Secundária de Loulé), S. Meireles, Candida Ines Costa, Ana Karoliny Melo Martins, Marta Seladas(Administração Regional de Saúde de Lisboa e Vale do Tejo), Rita Pinho, Francisca Gonçalves(Administração Regional de Saúde de Lisboa e Vale do Tejo), Pedro Frazão(Centro Hospitalar de Lisboa Ocidental), Carolina Xavier de Sousa(Administração Regional de Saúde de Lisboa e Vale do Tejo)
Cited by 0
Related Papers
Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms of the Rectum: A Case Report
|Case Reports in Oncology|2024|4
Male Breast Cancer in Portugal: A Descriptive Analysis of a 20-Year Cohort
|European Journal of Breast Health|2025|2
P-191 Ampullary neoplasms – how to treat in real-world practice? A retrospective study
|Annals of Oncology|2022|0
P-351 Colon cancer in young patients – real-world data from a single center review
|Annals of Oncology|2023|0
Neoadjuvant cisplatin-based chemotherapy (NAC) in Muscle-invasive bladder cancer (MIBC): Real-world data
|European Urology Open Science|2023|0